Hemas Holdings PLC, a Sri Lankan conglomerate with a focus on consumer brands, healthcare, and mobility, recently announced upcoming changes to its Board of Directors.

Husein Esufally, who has served Hemas for over four decades in various leadership capacities including Group Chief Executive Officer and Chairperson, will retire from the Board with effect from 31 December. Under his stewardship, Hemas evolved into one of Sri Lanka’s most respected and diversified conglomerates, delivering consistent value to stakeholders. 

The Board of Directors and the Hemas Group expressed its profound appreciation for his vision and dedication, which have been instrumental in shaping the Group’s purpose-driven culture and long-term success. The Group also announced that Deputy Chairperson, Dr. Anura Ekanayake, will retire on 31 December upon completion of his term. 

Dr. Ekanayake’s contributions to the Board and the Group have been significant, particularly in strengthening governance and providing strategic counsel during periods of transformation.

Effective 1 January 2026, Ajith Fernando will assume the role of Chairperson of Hemas Holdings PLC. A veteran in investment banking with over 30 years of experience, Fernando is widely recognised for his strategic insight and disciplined execution. His proven track record in building and scaling businesses positions him to guide Hemas through its next phase of growth and innovation.

To ensure continuity and reinforce Board oversight, Murtaza Esufally, current Chairperson of the Healthcare cluster, has been appointed Deputy Chairperson of Hemas Holdings PLC, effective 1 January 2026. His deep industry expertise and longstanding leadership within the Group will support Hemas’ strategic priorities and governance framework.